Cargando…
Opioid antagonists to prevent olanzapine-induced weight gain: A systematic review
INTRODUCTION: Olanzapine (OLZ) is a second generation antipsychotic that is approved for the treatment of schizophrenia, bipolar disorder type 1 as monotherapy (acute manic or mixed episodes, maintenance), or as an add-on to lithium or valproate (manic or mixed episodes). It is one of the most effec...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Association of Psychiatric Pharmacists
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405627/ https://www.ncbi.nlm.nih.gov/pubmed/36071739 http://dx.doi.org/10.9740/mhc.2022.08.254 |